FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety ...

Cedars-Sinai investigators working to optimize a cell-based treatment for retinitis pigmentosa have uncovered how ...

In this expert perspective from Retina 2026, Ehsan Rahimy, MD, a retina specialist at Palo Alto Medical Foundation, discussed promising advancements in the treatment of retinal diseases.Rahimy said th ...

We believe SVT-001 provides true hope to prevent the almost inevitable vision loss caused by this devastating condition ...

Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

Key market opportunities lie in AAV gene therapy advancements for hereditary retinal diseases. Future prospects include combination with CRISPR for precise genome editing, novel delivery platforms, ...

Black patients with inherited retinal diseases who undergo genetic testing are less likely than White patients to receive a conclusive genetic diagnosis, new research shows. At one center, about 39% ...

"Monogenic" diseases, triggered by mutations in just one gene, may actually be more complex than scientists thought.

Science has added a whole lot more cash to the bank, bringing in an impressive $230 million in its latest raise. | Science has added a whole lot more cash to the bank, bringing in an impressive $230 ...

Recent studies hint that subtle shifts in the peripheral retina could flag Alzheimer’s disease years before brain damage or ...

For the longest time, successfully transplanting an entire eye has been beyond reach, but a new study brings hope that they ...